全球的定點照護（POC）診斷市場

本報告已在2012年01月10日停止出版。

更改為出版

全球醫護站(POC)診斷市場

Point of Care Diagnostics

出版日期 : 2012年01月

商品編碼: 228049

簡介

本報告書內容包括：全球定點照護（POC）診斷市場的現況與展望的調查分析，檢查類型•地區別的市場成長預測（至2014年）、主要製造業者的市場至、各種市場影響因素、已上市產品的概要、利用技術、主要參與企業的簡介等，內容綱要摘記如下：

第1章 介紹

第2章 摘要

第3章 產業概要

• POC檢查概要
• POC市場概要
• 臨床診斷產業結構中的POC
• 即時診斷檢查的醫療面優勢
• POC檢查據點
• 家庭用／自我照護
• 急診室（ER）
• 加護病房（CCU）
• 臨床檢查
• 手術室（OR）處理室（PR）
• 醫師的辦公室／診所／治療中心／其他
• POC產品區分
• POC臨床分析類
• 一般的POC檢查
• 美國CLIA的重要性
• 其他的管理機關
• POC市場的牽引因素
• 成本上的制約
• 全球性全球性醫療從業人員的缺乏
• 技術的前進
• 發病率的變化

第4章 POC市場

• 市場概要
• 企業的市場佔有率
• POC市場參與企業的市場佔有率
• 市場構造
• 流通
• 推廣
• 策略性的合作•合併
• 市場組成
• 血液化學•電解質檢查
• 心肌標幟物檢查
• 膽固醇檢查
• 藥物•酒精中毒檢查
• 血糖值檢查
• 感染症檢查
• 單核球症檢查
• 懷孕•孕性測試
• 血紅蛋白/止血
• 主要標幟物檢查
• 尿化學檢查
• MISC檢查

第5章 技術應用

• 生物感應器
• 電極

第6章 專利分析

第7章 全球的POC市場

• 市場規模
• 全球市場的市場佔有率
• 製造業者的存在

第8章 主要企業簡介

第9章 附錄

目錄

Abstract

• Global POC market was worth nearly $13.4 billion in 2009, it is estimated to increase to $18.7 billion, at 5 year compound annual growth rate (CAGR) of 7.0%.
• The largest test blood chemistry and electrolyte market was nearly $2.1 billion in 2009. This is expected to rise to $3.8 billion in 2014, at a CAGR of 12.0%.
• Glucose monitoring test market reached approximately $7.7 million in 2009 and is projected to reach $9.9 billion in 2014, at a CAGR of 5.1%.

SCOPE OF REPORT

This study will describe the market for POC Diagnostics at the global level. It focuses on the accelerating growth in this important diagnostic market segment and the key industry players.

• Describes the POC industry.
• Estimates the current and future market size.
• Provides breakdowns for U.S. markets.
• Describes product segments and the continuous updating of POC products.
• Analyzes market influences in the industry and predicts the changes that will shape the future POC market.
• Discusses trends within the market and provides a future outlook
• Reviews business activities of market leaders.
• Lists patents for POC technologies.

METHODOLOGY

The information for this BCC report was obtained through primary and secondary data-collection methods. Primary methods included interviews with key representatives in the industry - product development managers, clinical specialists, government departments, and other key representatives involved in the diagnostic industry. Secondary methods included published literature, investment reports, company literature, and various business journals that focus on diagnostic products and technologies. Market data for this report pertains to the worldwide market, with specific U.S. data included. All information is displayed using U.S. dollars at the manufacturers' level. The base year of the report is 2009, with historical data provided for 2007 and 2008, and forecast data provided through 2014. Historical, base year, and forecast data are provided for each of the 10 market segments in the report. Compound annual growth rates (CAGRs) are determined through a compilation of data, including past trends, future trends, demographics, incidence of disease, products in research and development, current product growth, and trends in government regulations. Competitor market share estimates are provided for each market segment for the 2009 base year.

ANALYST CREDENTIALS

Melissa Elder is an experienced healthcare market analyst, specializing in prescription and over-the-counter pharmaceuticals, medical devices, animal health products, and emerging healthcare technologies. Ms. Elder has more than 13 years of experience in the healthcare industry, specializing in market research for the past 10 years. This experience has given her substantial insight into pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare markets.

Table of Contents

Point of Care Diagnostics

Chapter- 1: INTRODUCTION -- Complimentary

• STUDY GOALS AND OBJECTIVES
• REASONS FOR DOING THE STUDY
• SCOPE OF REPORT
• DEFINING POC
• METHODOLOGY
• ANALYST CREDENTIALS
• RELATED REPORTS
• BCC ONLINE SERVICES
• DISCLAIMER

Chapter-2: SUMMARY

• OVERVIEW
• MAJOR FINDINGS
• SUMMARY TABLE FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, THROUGH 2014 ($ MILLIONS)
• SUMMARY FIGURE FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, 2009 AND 2014 ($ MILLIONS)

Chapter-3: INDUSTRY OVERVIEW

• WHAT IS POC TESTING?
• OVERVIEW OF POC MARKET
• POC AS PART OF CLINICAL DIAGNOSTICS INDUSTRY STRUCTURE
• MEDICAL BENEFITS DERIVED FROM IMMEDIATE DIAGNOSTIC TESTING
• POC TESTING SITES
  • TABLE 1 SELECTED KEY STATISTICS FOR POC TESTING SITES
• HOME USE/SELF-CARE
• EMERGENCY ROOMS (ER)
• CRITICAL-CARE UNITS (CCU)
• BEDSIDE TESTING
  • TABLE 2 NUMBER OF HOSPITALS FOR SELECTED COUNTRIES, 2009
• OPERATING ROOMS (OR)/PROCEDURE ROOMS (PR)
• PHYSICIANS OFFICES/ CLINICS/ TREATMENT CENTERS/OTHER NONCRITICAL=CARE SITES
  • TABLE 3 NUMBER OF U.S. HEALTHCARE FACILITIES BY TYPE, 2006*
• POC PRODUCT SEGMENTS
• POC CLINICAL ASSAY CATEGORIES
• Blood Chemistry and Electrolytes
• Cardiac Marker
• Cholesterol Testing/Monitoring
• Drug and Alcohol Screening
• Glucose Testing and Monitoring
• Infectious Disease Testing
• Pregnancy and Fertility Testing
• Hemoglobin and Hemostasis
• Tumor Marker
• Urinalysis/Urine Chemistry
• COMMONLY PERFORMED POC TESTS
  • TABLE 4 SELECTED POC TESTS - CLIA WAIVED
  • TABLE 4 (CONTINUED)
• SIGNIFICANCE OF CLIA IN THE UNITED STATES
• SIGNIFICANCE OF CLIA IN THE UNITED STATES (CONTINUED)
• OTHER REGULATORY AGENCIES
• FDA
• Good Manufacturing Practice (GMP)
  • TABLE 5 PERTINENT PARAMETERS OF GMP REGULATIONS AFFECTING IN VITRO DIAGNOSTICS
• DRIVING FORCES OF THE POC MARKET
• COST CONTAINMENT
• Rising Healthcare Costs
  • TABLE 6 HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY, 1980-2006 (%)
  • FIGURE 1 HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY, 1980-2006 (%)
• Average Length of Stay
  • TABLE 7 HOSPITAL USAGE STATISTICS, BY COUNTRY (DAYS)
  • FIGURE 2 HOSPITAL USAGE STATISTICS, BY COUNTRY (DAYS)
• GLOBAL SHORTAGE OF HEALTHCARE WORKERS
• TECHNOLOGICAL ADVANCEMENT
• Availability - Ease of Use Devices
• New Technologies
• Biosensors
• CHANGES IN INCIDENCE OF DISEASE
  • TABLE 8 PREVALENCE OF SELECTED DISEASES IN THE GLOBAL POPULATION, 2008-2009 (MILLION CASES)
• Asthma
• Cardiovascular Disease
• Cancer
• Diabetes
• Diarrheal Disease
• HIV
• Infertility
• Influenza
• Malaria
• Pregnancy
• Pulmonary Disease
• Tuberculosis
• Aging Population
  • TABLE 9 ESTIMATED WORLD POPULATION AND ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030 (MILLIONS)
  • FIGURE 3 ESTIMATED WORLD POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000 - 2030 (MILLIONS)
  • TABLE 10 WORLD POPULATION BY SELECTED COUNTRY, THROUGH 2014 (MILLIONS)
  • FIGURE 4 WORLD POPULATION BY SELECTED COUNTRY, 2007 - 2014 (MILLIONS)

Chapter-4: THE POC MARKET

• MARKET OVERVIEW
  • TABLE 11 GLOBAL FORECAST FOR THE POC MARKET BY SEGMENT, THROUGH 2014 ($ MILLIONS)
  • FIGURE 5 GLOBAL FORECAST FOR THE POC MARKET BY SEGMENT, 2007-2014 ($ MILLIONS)
• COMPETITOR MARKET SHARE
• COMPETITOR MARKET SHARE (CONTINUED)
  • TABLE 12 MARKET SHARE OF POC MARKET PARTICIPANTS, 2009 (PERCENT/$ MILLIONS)
• MARKET SHARE OF POC MARKET PARTICIPANTS, 2009 (%)
• MARKET STRUCTURE
• DISTRIBUTION
  • FIGURE 7 DISTRIBUTION CHANNELS: POC DIAGNOSTIC DEVICES
• PROMOTION
• STRATEGIC ALLIANCES AND MERGERS
• MARKET COMPONENTS
• BLOOD CHEMISTRY AND ELECTROLYTE TESTING
• Blood Chemistry Parameters
• Electrolytes
• CLIA Quality Control (QC) Requirements for Blood Gas Analysis
• Market Size
  • TABLE 13 FORECAST OF THE GLOBAL POC BLOOD GAS/ELECTROLYTE TESTING MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 8 FORECAST OF THE GLOBAL POC BLOOD GAS/ELECTROLYTE TESTING MARKET BY REGION, 2007-2014 ($ MILLIONS)
• Market Participants and Market Shares
  • TABLE 14 RELATIVE MARKET SHARE OF POC BLOOD CHEMISTRY ANALYZER MANUFACTURERS BY COMPANY, 2009 (PERCENT/$ MILLIONS)
  • FIGURE 9 RELATIVE MARKET SHARE BLOOD GAS ANALYZER MANUFACTURERS BY COMPANY, 2009 (%)
  • TABLE 15 RECENTLY (2008 - 2009) CLIA-APPROVED BLOOD CHEMISTRY ANALYZERS
• Radiometer America, Inc.
• ABL80 FLEX
• NPT7
• RADIANCE STAT Analyzer and Data Management Software 47
• Nova Biomedical 47
• Stat Profile pHOx Product Line
  • TABLE 16 NOVA BIOCHEMICAL POC STAT PROFILE PHOX SERIES BY AVAILABLE TESTS
• Stat Profile CCX Product Line 49
  • TABLE 17 NOVA BIOCHEMICAL POC STAT PROFILE CCX SERIES BY AVAILABLE TESTS 49
• Point-of-Care Manager (PDM)
• Cumulative Patient Reports
• Siemens Healthcare
• RAPIDPoint 400/405
• RAPIDComm Data Management System 51
• Roche Diagnostics
• Cobas b 121 System
• Cobas b 221 Blood Gas System
• Abbott Diagnostics
• i-STAT
• International Technidyne Corp. (ITC)
• IRMA TRUpoint Blood Analysis System 53
• AVOXimeter Whole Blood Co-Oximeter/Oximeter System
• CARDIAC MARKER TESTING
• Market Size
  • TABLE 18 FORECAST OF THE GLOBAL POC CARDIAC MARKER TESTING MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 10 FORECAST OF THE GLOBAL POC CARDIAC MARKER TESTING MARKET BY REGION, 2007-2014 ($ MILLIONS)
• Market Participants and Market Shares
  • TABLE 19 RELATIVE MARKET SHARE OF POC CARDIAC MARKER MANUFACTURERS BY COMPANY, 2009 (PERCENT/$ MILLIONS)
  • FIGURE 11 RELATIVE MARKET SHARE OF POC CARDIAC MARKER MANUFACTURERS BY COMPANY, 2009 (%)
• Inverness Medical Innovations
• Triage System
• Roche
• Cardiac Reader System
• Abbott
• iSTAT 1
• Response Biomedical
• RAMP System
• CHOLESTEROL TESTING
• Market Size
  • TABLE 20 FORECAST OF THE GLOBAL CHOLESTEROL POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 12 FORECAST OF THE GLOBAL CHOLESTEROL POC RAPID TEST MARKET, 2007-2014 ($ MILLIONS)
• Market Participants and Market Shares
  • TABLE 21 RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS)
  • FIGURE 13 RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%)
  • TABLE 22 RECENTLY (2008 - 2009) CLIA-APPROVED CHOLESTEROL TESTS
• Inverness Medical Innovations
• Roche Diagnostics
• Abaxis
• DRUG AND ALCOHOL ABUSE TESTING
• Market Size
  • TABLE 23 FORECAST OF THE GLOBAL DRUG AND ALCOHOL POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 14 FORECAST OF THE GLOBAL DRUG AND ALCOHOL POC RAPID TEST MARKET BY REGION, 2007-2014 ($ MILLIONS)
• Market Participants and Market Shares
  • TABLE 24 RELATIVE MARKET SHARE OF DRUG AND ALCOHOL POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (PERCENT/$ MILLIONS)
  • FIGURE 15 RELATIVE MARKET SHARE OF DRUG AND ALCOHOL POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%)
  • TABLE 25 RECENTLY (2008 - 2009) CLIA-APPROVED POC DRUG AND ALCOHOL SCREENING TESTS BY MANUFACTURER
  • TABLE 25 (CONTINUED)
• Inverness Medical Innovations
• Phamatech
• Psychemedics
• Orasure Technologies
• GLUCOSE TESTING
• Market Size
  • TABLE 26 FORECAST OF THE GLOBAL POC GLUCOSE METER MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 16 FORECAST OF THE GLOBAL POC GLUCOSE METER MARKET BY REGION, 2007-2014 ($ MILLIONS)
  • TABLE 27 MARKET SHARE FOR THE GLOBAL POC GLUCOSE METER MARKET BY COMPONENT, 2009 ($ MILLIONS)
  • FIGURE 17 MARKET SHARE FOR THE GLOBAL POC GLUCOSE METER MARKET BY COMPONENT, 2009 (%)
• Market Participants and Market Shares
  • TABLE 28 RELATIVE MARKET SHARE FOR GLUCOSE METERS AND SUPPLIES MANUFACTURERS BY COMPANY, 2009 (PERCENT/$ MILLIONS)
  • FIGURE 18 RELATIVE MARKET SHARE FOR GLUCOSE METERS AND SUPPLIES MANUFACTURERS BY COMPANY, 2009 (%)
  • TABLE 29 RECENTLY (2008 - 2009) APPROVED CLIA-WAIVED BLOOD GLUCOSE METERS BY MANUFACTURER
  • TABLE 29 (CONTINUED)
  • TABLE 29 (CONTINUED)
  • TABLE 29 (CONTINUED)
• Roche Diagnostics
• Accu-Chek Active System
• Accu-Chek Inform System 7
• Accu-Chek Inform II
• Accu-Chek Voicemate System
• Johnson and Johnson
• LifeScan - OneTouch Ultra Meter
• LifeScan - OneTouch Ultra 2 Meter
• LifeScan OneTouch UltraSmart Meter
• LifeScan OneTouch InDuo System
• LifeScan OneTouch Basic Meter
• LifeScan OneTouch SureStep Meter
• LifeScan OneTouch UltraLink Meter 81
• LifeScan OneTouch Diabetes Management Software
• Abbott Diabetes Care
• FreeStyle Blood Glucose Monitoring System 82
• Precision Xtra Blood Glucose and Ketone Monitoring System
• i-STAT 1
• Home Diagnostics, Inc.
• Sidekick Testing System
• TrueTrack Smart System
• Prestige IQ Blood Glucose Monitor
  • TABLE 30 SELECTED LISTING OF RETAILERS SELLING HOME DIAGNOSTIC' S METERS
• Data Management Systems
  • TABLE 31 SELECTED LISTING OF BLOOD GLUCOSE MONITORS CAPABLE OF INTERACTING WITH COMPUTER SOFTWARE BY COMPANY
• INFECTIOUS DISEASE TESTING
• Strep A
  • TABLE 32 RECENTLY (2008 - 2009) CLIA-APPROVED STREP A TESTS BY MANUFACTURER
• Influenza
  • TABLE 33 RECENTLY (2008 - 2009) CLIA-APPROVED INFLUENZA TESTS BY MANUFACTURER
• Chlamydia/Trichomonas
• RSV
  • TABLE 34 RECENTLY (2008 - 2009) CLIA-APPROVED RSV TESTS BY MANUFACTURER
• HIV Testing
• Inverness Medical
• OraSure
• Trinity Biotech, plc
• Infectious Mononucleosis
  • TABLE 35 RECENTLY (2008 - 2009) CLIA-APPROVED INFECTIOUS MONONUCLEOSIS TESTS
• H. pylori
  • TABLE 36 RECENTLY (2008 - 2009) CLIA-APPROVED H. PYLORI TESTS BY MANUFACTURER
• Market Size
  • TABLE 37 FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 19 FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET BY REGION, 2007-2014 ($ MILLIONS)
  • TABLE 38 MARKET SHARE FOR THE GLOBAL POC INFECTIOUS DISEASE MARKET BY TEST TYPE, 2009 ($ MILLIONS)
  • FIGURE 20 MARKET SHARE FOR THE GLOBAL POC INFECTIOUS DISEASE MARKET BY TEST TYPE, 2009 (%)
• Market Participants and Market Shares
  • TABLE 39 RELATIVE MARKET SHARE OF INFECTOUS DISEASE POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS)
  • FIGURE 21 RELATIVE MARKET SHARE OF INFECTIOUS DISEASE POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%)
• Strep A
• Influenza
• Chlamydia
• PREGNANCY AND FERTILITY TESTING
• Market Size
  • TABLE 40 FORECAST OF THE GLOBAL PREGNANCY/FERTILITY POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 22 FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 41 MARKET SHARE FOR THE GLOBAL POC PREGNANCY/FERTILITY MARKET BY TEST TYPE, 2009 (PERCENT/$ MILLIONS)
  • FIGURE 23 MARKET SHARE FOR THE GLOBAL POC PREGNANCY/FERTILITY MARKET BY TEST TYPE, 2009 (%)
• Market Participants and Market Shares
  • TABLE 42 RELATIVE MARKET SHARE OF PREGNANCY/FERTILITY POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS)
  • FIGURE 24 RELATIVE MARKET SHARE OF PREGNANCY/FERTILITY POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%)
  • TABLE 43 RECENT (2008 - 2009) CLIA APPROVED PREGNANCY TESTS BY MANUFACTURER
  • TABLE 43 (CONTINUED)
• HEMOGLOBIN/HEMOSTASIS
• Hematology and Hemostasis
• Hemostasis (Coagulation)
• Market Size
  • TABLE 44 FORECAST OF THE GLOBAL HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 25 FORECAST OF THE GLOBAL HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MARKET BY REGION, 2007-2014 ($ MILLIONS)
• Market Participants and Market Shares
  • TABLE 45 RELATIVE MARKET SHARE OF HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS)
  • FIGURE 26 RELATIVE MARKET SHARE OF HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%)
  • TABLE 46 RECENTLY (2008 - 2009) CLIA APPROVED HEMATOLOGY TESTS
• TUMOR MARKER TESTING
• Fecal and Gastric Occult Blood
• Bladder Tumor Antigen Test
• Market Size
  • TABLE 47 FORECAST OF THE GLOBAL TUMOR MARKER POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 27 FORECAST OF THE GLOBAL TUMOR MARKER POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
• Market Participants and Market Shares
  • TABLE 48 RELATIVE MARKET SHARE OF TUMOR MARKER POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS)
  • FIGURE 28 RELATIVE MARKET SHARE OF TUMOR MARKER POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%)
  • TABLE 49 RECENTLY (2008 - 2009) CLIA APPROVED FECAL OCCULT BLOOD TESTS BY MANUFACTURER
• URINE CHEMISTRY TESTING
• Market Size
  • TABLE 50 FORECAST OF THE GLOBAL POC URINE CHEMISTRY ANALYZER MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 29 FORECAST OF THE GLOBAL POC URINE CHEMISTRY ANALYZER MARKET, 2007-2014 ($ MILLIONS)
• Market Participants and Market Shares
  • TABLE 51 RELATIVE MARKET SHARE OF POC URINE CHEMISTRY ANALYZER MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS)
  • FIGURE 30 RELATIVE MARKET SHARE OF POC URINE CHEMISTRY ANALYZER MANUFACTURERS BY COMPANY, 2009 (%)
  • TABLE 52 RECENTLY (2008 - 2009) CLIA-APPROVED URINE CHEMISTRY ANALYZERS BY MANUFACTURER
  • TABLE 52 (CONTINUED)
• MISC TESTING
• Vaginal pH Tests
  • TABLE 53 RECENTLY (2008 - 2009) CLIA-APPROVED VAGINAL PH TESTS BY MANUFACTURER
• Thyroid Stimulating Hormone (TSH) Tests
  • TABLE 54 RECENTLY (2008 - 2009) CLIA-APPROVED TSH TESTS BY MANUFACTURER
• Male Reproductive Tests
  • TABLE 55 RECENTLY (2008 - 2009) CLIA-APPROVED MALE REPRODUCTIVE TEST BY MANUFACTURER

Chapter-5: TECHNOLOGY APPLICATIONS

• BIOSENSORS
• WHAT ARE BIOSENSORS?
• Catalytic Sensors
• Affinity Sensors
• ELECTRODES
• WHAT ARE ELECTRODES?
• What are Electrodes? (Continued)

Chapter-6: PATENT ANALYSIS

• NUMBER OF RECENTLY ISSUED PATENTS
  • TABLE 56 RESULTS OF U.S. PATENT SEARCH FOR POC CATEGORIES, SEPTEMBER 2008--SEPTEMBER 2009 (NUMBER)
  • FIGURE 31 U.S. PATENTS BY POC CATEGORIES, SEPTEMBER 2008-SEPTEMBER 2009 (NUMBER)
• ANALYSIS OF PATENT BY SUBJECT
  • TABLE 57 U.S. PATENTS BY SUBJECT AREA, SEPTEMBER 2008 TO SEPTEMBER 2009 (NUMBER)
• PATENT ASSIGNEES
  • TABLE 58 U.S. PATENT ASSIGNEES, SEPTEMBER 2008 TO SEPTEMBER 2009 (NUMBER)
  • FIGURE 32 U.S. PATENTS BY COUNTRY, SEPTEMBER 2008-SEPTEMBER 2009 (NUMBER)
• RECENTLY ISSUED PATENTS
• GLUCOSE METERS
• HEMATOLOGY
• Hematology (Continued)
• COAGULATION ASSAY
• IMMUNOASSAY
• HEMATOLOGY
• Hematology (Continued)

Chapter-7: WORLDWIDE POC MARKET

• MARKET SIZE
  • TABLE 59 GLOBAL FORECAST (U.S. AND WORLDWIDE) FOR THE POC MARKET, THROUGH 2014
  • TABLE 59 (CONTINUED)
  • FIGURE 33 GLOBAL (U.S. AND WORLDWIDE) FORECAST FOR THE POC MARKET 2009 AND 2014 ($ MILLIONS)
• GLOBAL MARKET SHARES
  • TABLE 60 POC GLOBAL MARKET SHARE BY COUNTRY, 2009 (PERCENT/$ MILLIONS)
  • FIGURE 34 POC GLOBAL MARKET SHARE BY COUNTRY, 2009 (%)
• PRESENCE OF MANUFACTURERS IN THE WORLDWIDE MARKET
  • TABLE 61 MARKET SHARE OF TOP 10 POC MARKET PARTICIPANTS, 2009 ($ MILLIONS)
  • FIGURE 35 MARKET SHARE OF TOP 10 POC MARKET PARTICIPANTS, 2009 (%)

Chapter-8: PROFILES OF MAJOR MARKET PARTICIPANTS

• OVERVIEW OF MARKET PARTICIPANTS
• COMPANY PROFILES
• ABAXIS
  • TABLE 62 ABAXIS' COMPANY REVENUES, 2007 - 2010* ($ MILLIONS)
• ABBOTT LABORATORIES
  • TABLE 63 ABBOTT' S COMPANY REVENUES, 2006 - 2009 ($ MILLIONS)
• BECTON, DICKINSON, & CO.
  • TABLE 64 BD' S COMPANY REVENUES, 2006 - 2009 ($ MILLIONS)
• DANAHER CORP./RADIOMETER
  • TABLE 65 DANAHER' S COMPANY REVENUES, 2006 - 2009 ($ MILLIONS)
• INTERNATIONAL TECHNIDYNE CORP.
  • TABLE 66 THORATEC' S COMPANY REVENUES, 2006 - 2009 ($ MILLIONS)
• INVERNESS MEDICAL INNOVATIONS
  • TABLE 67 INVERNESS MEDICAL' S COMPANY REVENUES, 2006 - 2009 ($ MILLIONS)
• JOHNSON & JOHNSON
  • TABLE 68 JOHNSON & JOHNSON' S COMPANY REVENUES, 2006 - 2009 ($ MILLIONS)
• NOVA BIOMEDICAL
• ORASURE TECHNOLOGIES
• OraSure Technologies (Continued)
  • TABLE 69 ORASURE' S COMPANY REVENUES, 2006 - 2009 ($ MILLIONS)
• QUIDEL CORP.
  • TABLE 70 QUIDEL' S COMPANY REVENUES, 2006 - 2009 ($ MILLIONS)
• ROCHE
  • TABLE 71 ROCHE GROUP' S REVENUES, 2006 - 2009 ($ MILLIONS)
• SIEMENS MEDICAL SOLUTIONS
  • TABLE 72 SIEMENS' COMPANY REVENUES, 2006 - 2009 ($ MILLIONS)

Chapter-9: APPENDIX

• APPENDIX
• KEY SOURCES OF INFORMATION
• ABAXIS
• ABBOTT LABORATORIES
• BECKMAN COULTER, INC.
• CHURCH & DWIGHT CO., INC.
• CLINICAL DIAGNOSTICS DIVISION
• BECTON DICKINSON & CO.
• HEMOCUE AB
• HENRY SCHEIN, INC.
• HOME DIAGNOSTICS, INC.
• INTERNATIONAL TECHNIDYNE CORP.
• INVERNESS MEDICAL INNOVATIONS
• JOHNSON & JOHNSON
• NOVA BIOMEDICAL
• ORASURE TECHNOLOGIES
• PHAMATECH, INC.
• PSS WORLD MEDICAL, INC.
• PSYCHEMEDICS CORP.
• QUEST DIAGNOSTICS
• QUIDEL CORP.
• RADIOMETER AMERICA, INC.
• RESPONSE BIOMEDICAL CORP.
• ROCHE
• SIEMENS MEDICAL SOLUTIONS
• TRINITY BIOTECH, PLC

相關商品

矚目市場調查報告書

全套市場調查報告定期訂閱

Market Research Report Subscription

體外診斷設備相關市場調查報告書

全球切片設備市場:開發平台分析，競爭環境，到2018年為止的市場預測
Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
價格 : US $ 3995
出版日期 : 2012年04月

全球分子診斷市場:各國的設施·檢驗數量·銷售額預測
2012 World Molecular Diagnostics Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country
價格 : US $ 1850
出版日期 : 2012年04月

全球微生物測試市場展望：成長機會及業務拓展策略
2012 Microbiology Testing Market Outlook: Growth Opportunities and Strategies
價格 : US $ 28700
出版日期 : 2012年04月

BCC Research發行的醫療設備相關市場調查報告書

全球家用醫療設備市場及技術:新興市場的焦點

Global Markets and Technologies for Home Medical Equipment--Focus on Emerging Markets

價格 : US $ 3900

出版日期 : 2012年03月

對全球家用醫療設備市場及技術:金磚四國的焦點

Global Markets and Technologies for Home Medical Equipment--Focus on BRIC Countries

價格 : US $ 3900

出版日期 : 2012年03月

全球家用醫療設備市場及技術:日本市場的焦點

Global Markets and Technologies for Home Medical Equipment--Focus on Japan

價格 : US $ 3900

出版日期 : 2012年03月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!